uniQure N.V. Insider Trades
NASDAQ: QUREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 57 · $22.08M
- Shares bought / sold
- 0 / 642.08K
- Net activity
- Net selling $22.1 million
uniQure N.V. insider activity
Over the last 12 months, uniQure N.V. insiders reported 90 transactions on SEC Form 4: 0 open-market purchases and 57 sales. Insiders bought $0 and sold $22.1 million worth of stock, for net insider selling of $22.1 million. The largest seller was Kapusta Matthew C, with $12.9 million in reported sales.
The most recent filing shows Kapusta Matthew C (CEO, Managing Director) reporting a transaction in 21,082 shares at $19.39 on Jul 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put QURE's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
QURE insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 2, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 7,600 | $348.76K | Form 4 |
| Jul 2, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 4,282 | $194.53K | Form 4 |
| Jul 2, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 9,200 | $408.76K | Form 4 |
| Jul 2, 2026 | Kapusta Matthew CCEO, Managing Director | Option exercise | 21,082 | $408.78K | Form 4 |
| Jun 30, 2026 | Abi-Saab WalidChief Medical Officer | Sale | 20,000 | $928.00K | Form 4 |
| Jun 30, 2026 | Abi-Saab WalidChief Medical Officer | Sale | 10,000 | $464.60K | Form 4 |
| Jun 30, 2026 | Abi-Saab WalidChief Medical Officer | Option exercise | 10,000 | $55.90K | Form 4 |
| Jun 30, 2026 | Kaye JackDirector | Sale | 17,060 | $792.10K | Form 4 |
| Jun 30, 2026 | Kaye JackDirector | Option exercise | 17,060 | $344.27K | Form 4 |
| Jun 30, 2026 | Kaye JackDirector | Sale | 4,107 | $190.93K | Form 4 |
| Jun 30, 2026 | Kaye JackDirector | Option exercise | 4,107 | $151.96K | Form 4 |
| Jun 26, 2026 | Abi-Saab WalidChief Medical Officer | Sale | 1,434 | $67.20K | Form 4 |
| Jun 25, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 28,716 | $1.44M | Form 4 |
| Jun 25, 2026 | Kapusta Matthew CCEO, Managing Director | Option exercise | 28,716 | $910.58K | Form 4 |
| Jun 24, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 6,696 | $334.80K | Form 4 |
| Jun 24, 2026 | Kapusta Matthew CCEO, Managing Director | Option exercise | 4,128 | $130.90K | Form 4 |
| Jun 18, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 37,015 | $1.85M | Form 4 |
| Jun 18, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 4,656 | $232.80K | Form 4 |
| Jun 18, 2026 | Kapusta Matthew CCEO, Managing Director | Option exercise | 4,656 | $147.64K | Form 4 |
| Jun 17, 2026 | Kaye JackDirector | Sale | 5,295 | $225.41K | Form 4 |
| Jun 17, 2026 | Kaye JackDirector | Option exercise | 5,295 | $167.90K | Form 4 |
| Jun 17, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 11,585 | $563.61K | Form 4 |
| Jun 17, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 33,334 | $1.50M | Form 4 |
| Jun 17, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 56,929 | $2.47M | Form 4 |
| Jun 17, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 32,581 | $1.47M | Form 4 |
| Jun 17, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 6,023 | $263.21K | Form 4 |
| Jun 17, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 23,977 | $1.02M | Form 4 |
| Jun 17, 2026 | Kapusta Matthew CCEO, Managing Director | Option exercise | 62,581 | $1.21M | Form 4 |
| Jun 17, 2026 | Balachandran MadhavanDirector | Sale | 1,690 | $71.99K | Form 4 |
| Jun 17, 2026 | Balachandran MadhavanDirector | Sale | 4,700 | $205.20K | Form 4 |
| Jun 17, 2026 | Balachandran MadhavanDirector | Sale | 5,295 | $249.29K | Form 4 |
| Jun 17, 2026 | Balachandran MadhavanDirector | Option exercise | 6,390 | $123.90K | Form 4 |
| Jun 17, 2026 | Balachandran MadhavanDirector | Option exercise | 5,295 | $167.90K | Form 4 |
| Jun 15, 2026 | Potts JeannetteChief Legal Officer | Sale | 5,237 | $144.91K | Form 4 |
| Jun 15, 2026 | Balachandran MadhavanDirector | Sale | 10,000 | $278.50K | Form 4 |
| Jun 15, 2026 | Balachandran MadhavanDirector | Option exercise | 10,000 | $84.90K | Form 4 |
| Jun 11, 2026 | Jacques Rachelle SuzanneDirector | Sale | 1,993 | $53.93K | Form 4 |
| Jun 11, 2026 | POST LEONARD EDirector | Sale | 1,993 | $53.93K | Form 4 |
| Jun 11, 2026 | Springhorn Jeremy P.Director | Sale | 1,993 | $53.93K | Form 4 |
| Jun 11, 2026 | Balachandran MadhavanDirector | Sale | 1,993 | $53.93K | Form 4 |
| Jun 11, 2026 | O'Keefe KylieChief Customer & Strat Officer | Sale | 15,936 | $431.23K | Form 4 |
| Jun 11, 2026 | Kaye JackDirector | Sale | 1,993 | $53.93K | Form 4 |
| Jun 11, 2026 | Gut RobertDirector | Sale | 2,726 | $73.77K | Form 4 |
| Jun 11, 2026 | Meek David D.Director | Sale | 1,993 | $53.93K | Form 4 |
| Jun 10, 2026 | Jacques Rachelle SuzanneDirector | Award | 7,550 | — | Form 4 |
| Jun 10, 2026 | POST LEONARD EDirector | Award | 7,550 | — | Form 4 |
| Jun 10, 2026 | Springhorn Jeremy P.Director | Award | 7,550 | — | Form 4 |
| Jun 10, 2026 | Balachandran MadhavanDirector | Award | 7,550 | — | Form 4 |
| Jun 10, 2026 | Kaye JackDirector | Award | 7,550 | — | Form 4 |
| Jun 10, 2026 | Gut RobertDirector | Award | 7,550 | — | Form 4 |
| Jun 10, 2026 | Gut RobertDirector | Sale | 1,780 | $46.37K | Form 4 |
| Jun 10, 2026 | Gut RobertDirector | Sale | 3,127 | $81.40K | Form 4 |
| Jun 10, 2026 | Gut RobertDirector | Sale | 2,645 | $68.96K | Form 4 |
| Jun 10, 2026 | Gut RobertDirector | Option exercise | 2,645 | $42.43K | Form 4 |
| Jun 10, 2026 | Meek David D.Director | Award | 7,550 | — | Form 4 |
| Jun 3, 2026 | Kaye JackDirector | Sale | 2,645 | $79.38K | Form 4 |
| Jun 3, 2026 | Kaye JackDirector | Option exercise | 2,645 | $42.43K | Form 4 |
| May 8, 2026 | Abi-Saab WalidChief Medical Officer | Sale | 20,000 | $500.00K | Form 4 |
| May 8, 2026 | Abi-Saab WalidChief Medical Officer | Sale | 25,000 | $627.50K | Form 4 |
| May 8, 2026 | Abi-Saab WalidChief Medical Officer | Option exercise | 25,000 | $139.75K | Form 4 |
| Mar 4, 2026 | KLEMT CHRISTIANChief Financial Officer | Sale | 12,000 | $108.72K | Form 4 |
| Mar 4, 2026 | KLEMT CHRISTIANChief Financial Officer | Award | 39,600 | — | Form 4 |
| Mar 4, 2026 | Abi-Saab WalidChief Medical Officer | Sale | 808 | $7.32K | Form 4 |
| Mar 4, 2026 | Abi-Saab WalidChief Medical Officer | Award | 41,700 | — | Form 4 |
| Mar 4, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 14,581 | $132.10K | Form 4 |
| Mar 4, 2026 | Kapusta Matthew CCEO, Managing Director | Award | 70,600 | — | Form 4 |
| Mar 4, 2026 | Potts JeannetteChief Legal Officer | Sale | 3,412 | $30.91K | Form 4 |
| Mar 4, 2026 | Potts JeannetteChief Legal Officer | Award | 35,400 | — | Form 4 |
| Mar 4, 2026 | O'Keefe KylieChief Customer & Strat Officer | Award | 19,800 | — | Form 4 |
| Mar 2, 2026 | Potts JeannetteChief Legal Officer | Sale | 8,578 | $85.35K | Form 4 |
| Mar 2, 2026 | Abi-Saab WalidChief Medical Officer | Sale | 1,660 | $16.52K | Form 4 |
| Mar 2, 2026 | KLEMT CHRISTIANChief Financial Officer | Sale | 12,532 | $124.69K | Form 4 |
| Mar 2, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 34,437 | $342.65K | Form 4 |
| Feb 25, 2026 | KLEMT CHRISTIANChief Financial Officer | Sale | 6,217 | $148.34K | Form 4 |
| Feb 25, 2026 | Kapusta Matthew CCEO, Managing Director | Sale | 12,378 | $295.34K | Form 4 |
| Jan 12, 2026 | Gut RobertDirector | Sale | 7,803 | $195.78K | Form 4 |
| Jan 12, 2026 | Gut RobertDirector | Sale | 500 | $12.52K | Form 4 |
| Jan 12, 2026 | Gut RobertDirector | Sale | 17,310 | $422.19K | Form 4 |
| Jan 12, 2026 | Gut RobertDirector | Option exercise | 17,810 | $250.76K | Form 4 |
| Jan 9, 2026 | Kaye JackDirector | Sale | 6,390 | $174.32K | Form 4 |
| Jan 9, 2026 | Kaye JackDirector | Option exercise | 6,390 | $123.90K | Form 4 |
| Nov 6, 2025 | Gut RobertDirector | Sale | 15,594 | $425.72K | Form 4 |
| Nov 6, 2025 | Gut RobertDirector | Sale | 15,840 | $431.16K | Form 4 |
| Nov 6, 2025 | Gut RobertDirector | Option exercise | 15,840 | $72.39K | Form 4 |
| Nov 4, 2025 | Kaye JackDirector | Sale | 17,810 | $540.18K | Form 4 |
| Nov 4, 2025 | Kaye JackDirector | Option exercise | 17,810 | $250.76K | Form 4 |
| Nov 4, 2025 | Kaye JackDirector | Sale | 11,000 | $333.74K | Form 4 |
| Nov 4, 2025 | Kaye JackDirector | Option exercise | 11,000 | $59.07K | Form 4 |
| Nov 4, 2025 | Kaye JackDirector | Sale | 10,000 | $303.60K | Form 4 |
| Nov 4, 2025 | Kaye JackDirector | Option exercise | 10,000 | $73.70K | Form 4 |
| Sep 26, 2025 | KLEMT CHRISTIANChief Financial Officer | Sale | 15,000 | $825.00K | Form 4 |
| Sep 26, 2025 | KLEMT CHRISTIANChief Financial Officer | Option exercise | 15,000 | $80.55K | Form 4 |
| Sep 24, 2025 | Kapusta Matthew CCEO, Managing Director | Sale | 5,022 | $209.37K | Form 4 |
| Sep 24, 2025 | Kapusta Matthew CCEO, Managing Director | Sale | 49,978 | $2.03M | Form 4 |
| Sep 24, 2025 | Kapusta Matthew CCEO, Managing Director | Sale | 60,000 | $2.40M | Form 4 |
| Sep 24, 2025 | Kapusta Matthew CCEO, Managing Director | Sale | 51,316 | $2.03M | Form 4 |
| Sep 24, 2025 | Kapusta Matthew CCEO, Managing Director | Option exercise | 175,000 | $1.09M | Form 4 |
| Sep 24, 2025 | Kapusta Matthew CCEO, Managing Director | Option exercise | 51,316 | $386.41K | Form 4 |
| Sep 24, 2025 | KLEMT CHRISTIANChief Financial Officer | Sale | 3,000 | $120.12K | Form 4 |
| Sep 24, 2025 | KLEMT CHRISTIANChief Financial Officer | Option exercise | 3,000 | $39.09K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4